Roivant Sciences CEO sells over $23 million in company stock
Roivant Sciences Ltd. (NASDAQ:ROIV) CEO Matthew Gline has recently engaged in significant transactions involving the company’s common shares, according to the latest
Roivant Sciences Ltd. (NASDAQ:ROIV) CEO Matthew Gline has recently engaged in significant transactions involving the company’s common shares, according to the latest
Roivant Sciences Ltd. (NASDAQ:ROIV) has reported a significant transaction involving its Chief Accounting Officer, Rakhi Kumar, who sold shares in the company.
By Rae Wee SINGAPORE (Reuters) – The Australian and New Zealand dollars scaled multi-month peaks on Wednesday while sterling hit its highest in
(Reuters) – Argentina’s government may condense negotiations with the International Monetary Fund (IMF) staff on its $44 billion program before opening talks
MANILA (Reuters) – Developing Asia is on track to grow 5% this year, supported by strong consumption and high demand for tech
TOKYO (Reuters) – The prices Japanese companies charge each other for services rose 2.7% in August from a year earlier, steady from
By Michael S. Derby NEW YORK (Reuters) – The central bank official responsible for implementing monetary policy at the New York Federal Reserve
In a recent move that has caught the attention of the market, Omni Retail Enterprises, LLC, a major stakeholder in Wilhelmina International,
By Lisa Baertlein and David Shepardson LOS ANGELES/WASHINGTON (Reuters) -Officials from President Joe Biden’s administration are monitoring labor talks but not trying to
Korn Ferry’s (NYSE:KFY) Chief Executive Officer of Professional Search, Michael Distefano, has sold 5,000 shares of the company’s stock at an average